Zhejiang Cancer Hospital

Hangzhou, Gongshu District 310022

1 studies enrolling now · 2 studies all time

What they study most

Hepatocellular Carcinoma (HCC), Solid Tumor

Studies at this site

• A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors — Recruiting now
• A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma — Completed